In Lazio, two cases have rekindled a theme that, with each new formal transition, immediately returns to the center. This time the point is precise: for two women from the province of Latina the causal link between anti-Covid vaccination and serious pathologies was recognized, a step that paves the way for the compensation provided by law. The news has weight, because it concerns real people, healthcare processes and serious consequences. But it needs to be told in full, without stopping at the effect the title has.
Two cases recognized in Lazio and the process that can lead to compensation
The two cases concern women resident in the province of Latina who had appealed. Based on what emerged, in one case damage was recognized following the administration of AstraZeneca, in the other after that of Pfizer. The decisive point is that we are not talking about a simple report or a suspicion reported verbally. Here a formal evaluation comes into play, with medical commissions called to examine medical records, times of onset of symptoms, investigations and possible alternative causes.
It is precisely this step that makes the difference. In fact, the recognition of the causal link allows the process for compensation to be opened. For those involved it means finally seeing something translated into an official act that until then had remained stagnant between visits, waiting and bureaucracy. It is an important point and should be treated for what it is: health news with concrete effects on people’s lives.
What should not be done, however, is to transform two individual cases into a good narrative shortcut to describe a general phenomenon without measure. Here we need an extra step.
What the scientific picture says about adverse events
When dealing with news of this type, the most delicate part often comes at the end. And it is also the one that is most easily sacrificed. Yet that is where the correctness of information comes into play. Vaccines, like all drugs, can have adverse effects. This applies to anti-Covid vaccines as well as other vaccines that have already been in use for years. The vast majority of reactions are mild and temporary. There is also a much smaller share of serious events, which remain rare or very rare and are monitored through pharmacovigilance systems. It is the normal picture of medicine.
Health authorities carefully distinguish between what happens after a vaccination and what is caused by the vaccination. It’s not a nicety: it’s the heart of pharmacovigilance. Each report is collected, analysed, compared with available data and inserted into a broader framework.
The WHO recalls that an AEFI, i.e. an adverse event after immunisation, does not automatically imply a causal relationship with the vaccine. Precisely for this reason there is pharmacovigilance and medico-legal evaluation of the connection. AIFA continues to publish surveillance reports and also monitor data relating to Covid vaccines as part of postmarketing surveillance.
In the case of anti-Covid vaccines, some rare events have been identified and recognized over time. Among these there are myocarditis and pericarditis associated with mRNA vaccines and particular thrombosis with thrombocytopenia for AstraZeneca. The European Medicines Agency (EMA) has classified them as rare or very rare events, including them in the monitoring of vaccine safety. In the case of myocarditis and pericarditis, the EMA reports that cases were mainly observed within 14 days of vaccination, more often after the second dose and particularly in younger males.
This does not erase individual cases. He places them. The recognition of damage in a medical-legal context remains an important step for those who experience it. It means access to a right, to protection. However, the scale of the phenomenon does not change, which continues to remain limited in numbers and monitored over time. There is a thin line between news and perception, and it doesn’t take much to move it. The risk lies not in the news, but in the way it is read.
You might also be interested in:
